This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Middle East Veterinary Vaccines Market

Market Insights on Middle East Veterinary Vaccines covering sales outlook, demand forecast & up-to-date key trends

Middle East Veterinary Vaccines Market by Vaccine (Attenuated Live Vaccines, Inactivated Vaccines, Toxoid Vaccines, DNA Vaccines, Recombinant Vaccines, and Others), By Animal (Companion Animals Livestock Animals and Equine) & Region for 2022-2031

Middle East Veterinary Vaccines Market Snapshot

[192 Pages Report] The Middle East Veterinary Vaccines Market is valued at US$ 335.0 Mn in 2021 and is expected to reach US$ 533.4 Mn by 2031, reflecting a cumulative CAGR of 4.8% over the forecast period (2022-2031) according to Future Market Insights (FMI) study.

Middle East Veterinary Vaccines Market Outlook:

Data Points

Market Insights

Market Value 2021

USD 335.0 Mn

Market Value 2022

USD 350.8 Mn

Market Value 2031

USD 533.4 Mn

Top 3 Country Share

51.2%

CAGR 2022-2031

4.8%

Key Players

The key players of this industry are JOVAC, Bioveta, Inc., Intervac Pvt. Ltd., Zoetis, Elanco, Merial, Merck & Co. Inc, Bayer Pharma AG, Ceva,

Boehringer Ingelheim

The need for veterinary vaccines has been gradually increasing over the past few years owing to the rise of foodborne and zoonotic diseases in the Middle Eastern countries, which makes vaccination a necessity for all the animals. The preventive treatment costs of these diseases is much lower when compared to the management costs, which create a favourable growth environment for this market over the forecast period.

For instance, a biannual mass vaccination program for foot and mouth disease, for cattle is carried out in Turkey to combat this disease. The sales of veterinary vaccines in Middle East is expected to reach U.S. $ 335.0 Mn in the year 2021.

Rising demand for processed food items around the world is fuelling the demand for effective vaccination of the livestock in countries which are the major producers of these products such as Sudan, Turkey, Egypt and KSA. Increased awareness about the quality of meat that is consumed, is majorly contributing to the demand of processed meat products around the world.

Beneficial ingredients that help fight disease and promote good health are being sought, even at premium rates, which drives the demand for processed meat and in turn is helping the growth of veterinary vaccines market in the middle eastern region. The growing sales of meat and meat products will positively impact the growth of Middle East veterinary vaccines market over the forecast period.

Rising per capita disposable income levels are largely contributing towards demand for processed food items. This is expected to drive growth of veterinary vaccines in poultry and livestock segments. Growing cases of anti-microbial drug resistance in both animals and human beings is a matter of concern for all the governmental authorities around the world. Thus, increasing governmental initiatives to adopt the use of veterinary vaccines instead of antimicrobials in farm animals as well as companion animals is expected to propel the demand for this market over the forecast period.

The live attenuated vaccines are expected to record sales worth U.S. $ 124.3 in the year 2022, which represented a cumulative market share of more than 35%. This trend is expected to continue over the forecast period which indicates many lucrative opportunities for the vaccine manufacturers in this segment.

Veterinary vaccine manufacturers are seeking collaboration at government levels or with domestic companies in the Gulf region to mass produce veterinary vaccines and tap the largely untapped market. With limited competitive intensity, the markets in the MEA region represent lucrative opportunity for players to enter.

Customize this Report

Let us know your requirement to get
100% FREE customization

2016-2021 Middle East Veterinary Vaccines Demand Outlook Compared to 2022-2031 Forecast

According to Future Market Insights (FMI), the industry registered a cumulative CAGR of 4.6% over the year 2016-2021. Middle East veterinary vaccines market accounts for approx. 4.4% of the overall global veterinary vaccines market that accounts around US$ 7.7 Bn.

The need for veterinary vaccines rose over the past few years owing to the rising awareness and importance of vaccination for livestock as well as companion animals. Growing demand for processed meat products, increasing per capita income, expenditure on good quality products and increased trade of livestock animals in the Middle Eastern countries are some of the key factors which helped the industry grow and will continue to positively affect the market demand over the forecast period.

The manufacturers of veterinary vaccines are actively seeking collaborations with the governmental authorities as well as amongst themselves to enter into the emerging markets of the Middle East. Key players are expanding their business segments by launching accompanying services to strengthen their position in the market.

Middle East Veterinary Vaccines Market Download Report Brochure

In September 2020, Bioveta Inc., expanded its business in Ukraine with the commission of their ELISA laboratory. Thi laboratory was built to study the antibody titres of selected diseases and post vaccination titres of cattle, poultry, pigs, dogs and rabbits.

Future Market Insights projects the Middle East veterinary vaccines market to expand at a CAGR of 4.8% by the end of 2031. The key players conducting various R&D activities and launching innovative products in the field of veterinary vaccines, participating in active collaborations to expand their market presence.

Custom-made vaccines to provide numerous opportunities for revenue generation

Custom vaccines are specifically manufactured to cater to a specific flock and they contain inactivated biological products. Custom vaccines can be used to target specific organisms which are not included in the commercial vaccines. This type of vaccine helps to fine tune the vaccination program with respect to the need of every animal.

This is a comparatively new field in terms of veterinary vaccines, which is expected to witness growing demand in the next few years. Boehringer Ingelheim is one of the key players who provide custom made vaccine services to improve the quality of life of the poultry animals.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What are the key opportunities for market players?

Companies acting as one-stop shop are expected to perform better than companies who are heavily reliant on imports. Extra regulation and costs for implementing guidelines drain on operating productivity of players. In this regard, foreign drug makers who have manufacturing presence in the region along with local players who are well positioned to tap the market are expected to perform better.

Greater focus on innovation to avoid zoonotic diseases coupled with advancements in biotechnology is expected to create a favourable platform for development of veterinary vaccines in high-income economies in the region such as UAE, KSA and Turkey. These techniques include next-generation sequencing, synthetic biology and systems biology, among others. Further, continued investments in multi-disciplinary vaccinology research could improve vaccine development efficiency and shorten time-to-market for upcoming veterinary vaccines.

Various product innovations, partnerships and collaborations are some of the key growth strategies adopted by the leading players of this industry. A less competitive environment in the emerging markets of the Middle Eastern countries create a favourable condition for these major players to tap into these market

What is the impact of the COVID-19 crisis on the market?

The COVID-19 pandemic had an equivocal impact on the veterinary vaccines market owing to a drop in demand as veterinary visits were limited and animal healthcare was shifted for treating emergency situations and severely ill animals.

Veterinary entities all across the world had urged that animal patient care to be limited to extremely sick animals and emergencies. Furthermore, the lockdowns had caused yearly check-ups and optional immunisation treatments to be rescheduled.  Various significant stakeholders, on the other hand, had secured the availability of animal vaccinations, since governments across the world were taking strong efforts to assure the supply, in order to prevent zoonotic infections from entering into animal populations.

For instance, Merck & Co. announced a growth of 7% in their worldwide sales of the animal health segment in 2020.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Country-wise Insights

Will Jordan remain a key market for veterinary vaccines in the Middle East?

Jordan accounted for approximately 20.1% of the total market share of Middle East veterinary vaccines in the year 2021 owing to rising incidence of food borne and zoonotic diseases and rising per capita disposable income in the region.

Additionally, the Ministry of Agriculture (MA) offers free veterinary services, both clinical and laboratory in Jordan. They offer free animal immunizations. Simultaneously, an increasing number of private veterinary clinics and pharmacies are opening, offering a variety of veterinary services and assistance.

Furthermore, mainly a few non-governmental organisations and institutes offer veterinary services and assistance in the region.

Why is Turkey the second largest market in Middle East?

Turkey is expected to grow at a cumulative CAGR of 6.4% over the forecast period in the veterinary vaccines industry. Growing demand for processed meat products, increased awareness about various foodborne and zoonotic disorders and growing demand for animal vaccination will help the industry expand in Turkey.

Category-wise Insights

What is the Middle East Veterinary Vaccines market value?

The Middle East veterinary vaccines market recorded sales worth U.S. $ 335.0 Mn in the year 2021 and is expected to reach U.S. $ 533.4 Mn by the year 2031. This market value growth reflects a cumulative CAGR of 4.8% over the forecast period (2022-2031).

Why the demand for attenuated live vaccines increasing?

The attenuated live vaccines accounted for 35.1% share of the total market of veterinary vaccines in the Middle East in 2021. The demand for attenuated live vaccines is expected to grow at a CAGR of 5.8% over the forecast period. By triggering a wide spectrum of immune responses, attenuated vaccines can deliver better immunity than conventional vaccinations. Furthermore, it helps to reduce the need for booster vaccinations that may be given orally and generates long-lasting and efficient immunity.

Additionally, increased demand for foot and mouth disease vaccination for cattle and other animals is one of the key driver which will help the veterinary vaccines market expand in the Middle Eastern region.

Which animals will drive the demand for veterinary vaccines market in the Middle East?

The livestock animals held the maximum share of 73.9% of the total veterinary vaccines market in terms of animal in 2021. Increased demand for processed meat products and making animal health a critical component of disease control is leading to increasing adoption of livestock animal’s vaccination in the Middle Eastern region.

Moreover, rising awareness regarding the importance of vaccines of livestock animals will drive the demand for veterinary vaccines market in the Middle East.

Which disease indication takes up the largest share in the Middle East veterinary vaccines market?

The foot and mouth disease accounted for more than 27% of the market share of the Middle East veterinary vaccines market in 2021. Foot and mouth disease is the most commonly occurring disease amongst all the animals. This creates lucrative opportunities for the foot and mouth disease vaccine manufacturers for growth over the forecast period. This segment is expected to project a cumulative CAGR of 5.6% over the forecast period.

How are private veterinary pharmacies driving the veterinary vaccines market?

The private veterinary pharmacies registered sales worth U.S. $ 114.6 Mn during the year 2021 and are expected to project a cumulative CAGR of 5.0% over the forecast period. Increased awareness regarding animal vaccinations, rising incidences of foot and mouth disease, high demand for good quality processed meat are some of the factors contributing to the growth of private veterinary pharmacies in the Middle East.

Which is the fastest growing country in the Middle East veterinary vaccines market?

The veterinary vaccines market in Jordan, is the fastest growing market and is expected to expand at a cumulative CAGR of 5.6% over the forecast period and accounted for approx. 20.1% market share in 2021.

Competitive Landscape

Companies operating in the veterinary vaccines market are actively seeking to strengthen their position through acquisitions, and strategic partnerships. These strategies help accelerate the manufacturer’s strategy to capitalize on the market share and capture the significant share of market. Some of the recent instances include:

In August 2020, Elanco Animal Health Inc. announced the acquisition of the animal health segment of Bayer AG.

In August 2021, Zoetis announced the acquisition of Jurox, which is a leading manufacturer of livestock and companion animal products. This acquisition was made to improve the product portfolio of the company and strengthen their position in the market.

The greater the demand for active products, the stronger is the pipeline, which will lead to increased demand for the market. Leading industry players are focusing on the development and launch of various innovative products in the field of veterinary vaccines. This creates numerous opportunities for investment in the industry.

Scope of the Report

Attribute

Details

Forecast Period

2022-2031

Historical Data Available for

2016-2021

Market Analysis

USD Million for Value.

Key Countries Covered

United Arab Emirates (UAE), Kingdom of Saudi Arabia (KSA), Turkey, Jordan, Sudan, Egypt and Rest of Middle East.

Key Segments Covered

Vaccine, Animal, Disease Indication, End-User and Countries.

Key Companies Profiled

Report Coverage

Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives

Customization & Pricing

Available upon Request

Middle East Veterinary Vaccines, by Category

By Vaccine:

  • Attenuated Live Vaccines
  • Inactivated Vaccines
  • Toxoid Vaccines
  • DNA Vaccines
  • Recombinant Vaccines
  • Others

By Animal:

  • Companion Animals
    • Canine
    • Avian
    • Feline
  • Livestock Animals
    • Aquatic
    • Bovine
    • Porcine
    • Small Ruminant
    • Poultry
  • Equine

By Disease Indication:

  • Foot and Mouth Disease
  • Newcastle Disease
  • PPRS
  • Canine Parvovirus
  • Brucellosis
  • Avian Influenza
  • Others

By End-User

  • Hospital Pharmacies
  • Veterinary Clinics
  • Private Veterinary Pharmacies
  • Others

By Country:

  • UAE
  • KSA
  • Turkey
  • Jordan
  • Sudan
  • Egypt
  • Rest of MEA

Frequently Asked Questions

The market is projected to reflect high demand in the forecast period with a CAGR of 4.8% owing to the declining popularity of antimicrobial agents for treating foodborne and zoonotic infections amongst animals, collaborative manufacturing efforts between key players and the governments, limited competitive intensity opening opportunities for various new manufacturers, growing number of foodborne and zoonotic diseases, high demand for processed food items, and non-existent interregional animal m

Jordan holds the largest market share of 20.1% of the total market share in this industry with a market value of U.S. $ 67.5 Mn recorded in the year 2021.

Some of the restraints that could hamper the growth of this market over the forecast period include the lack of resources for the collection of samples and questionable potency of the vaccines, lack of harmonized vaccine registration across the region and gaps in epidemiological knowledge of certain virulent veterinary diseases.

The key players of this industry are JOVAC, Bioveta, Inc., Intervac Pvt. Ltd., Zoetis, Elanco, Merial, Merck & Co. Inc., Bayer Pharma AG, Ceva, and Boehringer Ingelheim.

Table of Content

1. Executive Summary

    1.1. Middle East Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Trends in Veterinary Vaccines

4. Key Success Factors

    4.1. Key Vaccines USP Analysis

    4.2. Key Manufacturers Promotional Strategies

    4.3. Key regulations

    4.4. Value Chain Analysis

    4.5. PESTLE Analysis

    4.6. PORTERS Analysis

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Increasing government support hearing disabilities

        5.1.2. Improved economic conditions leading to increased penetration by companies

        5.1.3. Rise in R&D spending

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. Vaccine Launches

        5.2.2. R&D expenditure by key players

        5.2.3. Vaccine Adoption rate

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity

6. COVID-19 Crisis Analysis

    6.1. Current COVID19 Statistics and Probable Future Impact

    6.2. Current GDP Projection and Probable Impact

    6.3. Current Economic Projection as compared to 2008 Economic analysis

    6.4. COVID19 and Impact Analysis

        6.4.1. Revenue By Vaccine

        6.4.2. Revenue By Animal

        6.4.3. Revenue By Disease Indication

        6.4.4. Revenue By Distribution Channel

        6.4.5. Revenue By Country

    6.5. 2021 Market Scenario

    6.6. Recovery Scenario – Short term, Midterm and Long Term Impact

7. Middle East Veterinary Vaccines Market Volume (Units) Analysis 2016 – 2021 and Forecast, 2022 – 2031

    7.1. Historical Market Volume (Units) Analysis, 2016-2021

    7.2. Current and Future Market Volume (Units) Projections, 2022-2031

        7.2.1. Y-o-Y Growth Trend Analysis

8. Middle East Veterinary Vaccines Market – Pricing Analysis

    8.1. Country Level Pricing Analysis By Vaccine

    8.2. Pricing Break-up

        8.2.1. Manufacturer Level Pricing

        8.2.2. Distributor Level Pricing

    8.3. Middle East Average Pricing Analysis Benchmark

9. Middle East Veterinary Vaccines Market Demand (Size in US$ Mn) Analysis 2016–2021 and Forecast, 2022-2031

    9.1. Historical Market Value (US$ Mn) Analysis, 2016–2021

    9.2. Current and Future Market Value (US$ Mn) Projections, 2022-2031

    9.3. Y-o-Y Growth Trend Analysis

10. Middle East Veterinary Vaccines Market Analysis 2016–2021 and Forecast 2022-2031, by Vaccine

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) By Vaccine, 2016–2021

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Vaccine, 2022-2031

        10.3.1. Attenuated Live Vaccines

        10.3.2. Inactivated Vaccines

        10.3.3. Toxoid Vaccines

        10.3.4. DNA Vaccines

        10.3.5. Recombinant Vaccines

        10.3.6. Others

    10.4. Market Attractiveness Analysis By Vaccine

11. Middle East Veterinary Vaccines Market Analysis 2016–2021 and Forecast 2022-2031, by Animal

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Analysis By Animal, 2016–2021

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Animal, 2022-2031

        11.3.1. Companion Animals

            11.3.1.1. Canine

            11.3.1.2. Avian

            11.3.1.3. Feline

        11.3.2. Livestock Animals

            11.3.2.1. Aquatic

            11.3.2.2. Bovine

            11.3.2.3. Porcine

            11.3.2.4. Small Ruminant

            11.3.2.5. Poultry

        11.3.3. Equine

    11.4. Market Attractiveness Analysis By Animal

12. Middle East Veterinary Vaccines Market Analysis 2016–2021 and Forecast 2022-2031, by Disease Indication

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Analysis By Disease Indication, 2016 - 2021

    12.3. Current Market Size (US$ Mn) Analysis and Forecast By Disease Indication, 2022 - 2031

        12.3.1. Foot and Mouth Disease

        12.3.2. New Castle Disease

        12.3.3. PPRS

        12.3.4. Canine Parvovirus

        12.3.5. Brucellosis

        12.3.6. Avian Influenza

        12.3.7. Others

    12.4. Market Attractiveness Analysis By Disease Indication

13. Middle East Veterinary Vaccines Market Analysis 2016–2021 and Forecast 2022-2031, by Distribution Channel

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2016 - 2021

    13.3. Current Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2022 - 2031

        13.3.1. Hospital Pharmacies

        13.3.2. Veterinary Clinics

        13.3.3. Private Veterinary Pharmacies

        13.3.4. Others

    13.4. Market Attractiveness Analysis By Distribution Channel

14. Middle East Veterinary Vaccines Market Analysis 2016–2021 and Forecast 2022-2031, by Country

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016–2021

    14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2031

        14.3.1. UAE

        14.3.2. KSA

        14.3.3. Turkey

        14.3.4. Jordan

        14.3.5. Sudan

        14.3.6. Egypt

        14.3.7. Rest of MEA

    14.4. Market Attractiveness Analysis

15. United Arab Emirates (UAE) Veterinary Vaccines Value (in $ Mn) and Volume (000’ Units) Analysis 2016–2021 and Forecast 2022-2031

    15.1. Introduction

    15.2. Pricing Analysis

    15.3. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016 - 2021

    15.4. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2031

        15.4.1. By Vaccine

        15.4.2. By Animal

        15.4.3. By Disease Indication

        15.4.4. By Distribution Channel

    15.5. Market Attractiveness Analysis

        15.5.1. By Vaccine

        15.5.2. By Animal

        15.5.3. By Disease Indication

        15.5.4. By Distribution Channel

    15.6. Key Market Participants - Intensity Mapping

    15.7. Drivers and Restraints - Impact Analysis

16. Kingdom of Saudi Arabia (KSA) Veterinary Vaccines Value (in $ Mn) and Volume (000’ Units) Analysis 2016–2021 and Forecast 2022-2031

    16.1. Introduction

    16.2. Pricing Analysis

    16.3. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016 - 2021

    16.4. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2031

        16.4.1. By Vaccine

        16.4.2. By Animal

        16.4.3. By Disease Indication

        16.4.4. By Distribution Channel

    16.5. Market Attractiveness Analysis

        16.5.1. By Vaccine

        16.5.2. By Animal

        16.5.3. By Disease Indication

        16.5.4. By Distribution Channel

    16.6. Key Market Participants - Intensity Mapping

    16.7. Drivers and Restraints - Impact Analysis

17. Turkey Veterinary Vaccines Value (in $ Mn) and Volume (000’ Units) Analysis 2016–2021 and Forecast 2022-2031 

    17.1. Introduction

    17.2. Pricing Analysis

    17.3. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016 - 2021

    17.4. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2031

        17.4.1. By Vaccine

        17.4.2. By Animal

        17.4.3. By Disease Indication

        17.4.4. By Distribution Channel

    17.5. Market Attractiveness Analysis

        17.5.1. By Vaccine

        17.5.2. By Animal

        17.5.3. By Disease Indication

        17.5.4. By Distribution Channel

    17.6. Key Market Participants - Intensity Mapping

    17.7. Drivers and Restraints - Impact Analysis

18. Jordan Veterinary Vaccines Value (in $ Mn) and Volume (000’ Units) Analysis 2016–2021 and Forecast 2022-2031 

    18.1. Introduction

    18.2. Pricing Analysis

    18.3. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016 - 2021

    18.4. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2031

        18.4.1. By Vaccine

        18.4.2. By Animal

        18.4.3. By Disease Indication

        18.4.4. By Distribution Channel

    18.5. Market Attractiveness Analysis

        18.5.1. By Vaccine

        18.5.2. By Animal

        18.5.3. By Disease Indication

        18.5.4. By Distribution Channel

    18.6. Key Market Participants - Intensity Mapping

    18.7. Drivers and Restraints - Impact Analysis

19. Sudan Veterinary Vaccines Value (in $ Mn) and Volume (000’ Units) Analysis 2016–2021 and Forecast 2022-2031 

    19.1. Introduction

    19.2. Pricing Analysis

    19.3. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016 - 2021

    19.4. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2031

        19.4.1. By Vaccine

        19.4.2. By Animal

        19.4.3. By Disease Indication

        19.4.4. By Distribution Channel

    19.5. Market Attractiveness Analysis

        19.5.1. By Vaccine

        19.5.2. By Animal

        19.5.3. By Disease Indication

        19.5.4. By Distribution Channel

    19.6. Key Market Participants - Intensity Mapping

    19.7. Drivers and Restraints - Impact Analysis

20. Egypt Veterinary Vaccines Value (in $ Mn) and Volume (000’ Units) Analysis 2016–2021 and Forecast 2022-2031 

    20.1. Introduction

    20.2. Pricing Analysis

    20.3. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016 - 2021

    20.4. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2031

        20.4.1. By Vaccine

        20.4.2. By Animal

        20.4.3. By Disease Indication

        20.4.4. By Distribution Channel

    20.5. Market Attractiveness Analysis

        20.5.1. By Vaccine

        20.5.2. By Animal

        20.5.3. By Disease Indication

        20.5.4. By Distribution Channel

    20.6. Key Market Participants - Intensity Mapping

    20.7. Drivers and Restraints - Impact Analysis

21. Rest of Middle East Veterinary Vaccines Value (in $ Mn) and Volume (000’ Units) Analysis 2016–2021 and Forecast 2022-2031 

    21.1. Introduction

    21.2. Pricing Analysis

    21.3. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016 - 2021

    21.4. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2031

        21.4.1. By Vaccine

        21.4.2. By Animal

        21.4.3. By Disease Indication

        21.4.4. By Distribution Channel

    21.5. Market Attractiveness Analysis

        21.5.1. By Vaccine

        21.5.2. By Animal

        21.5.3. By Disease Indication

        21.5.4. By Distribution Channel

    21.6. Key Market Participants - Intensity Mapping

    21.7. Drivers and Restraints - Impact Analysis

22. Market Structure Analysis

    22.1. Market Analysis by Tier of Companies

    22.2. Market Concentration

    22.3. Market Share Analysis of Top Players

    22.4. Market Presence Analysis

        22.4.1. By Country Level footprint of Players

        22.4.2. Vaccine foot print by Players

        22.4.3. Channel Foot Print by Players

23. Competition Analysis

    23.1. Competition Dashboard

    23.2. Competition Benchmarking

    23.3. Competition Deep Dive

        23.3.1. Jovac

            23.3.1.1. Overview

            23.3.1.2. Vaccine Portfolio

            23.3.1.3. Profitability by Market Segments (Vaccine/Channel/Country)

            23.3.1.4. Sales Footprint

            23.3.1.5. Strategy Overview

        23.3.2. Bioveta, Inc.

            23.3.2.1. Overview

            23.3.2.2. Vaccine Portfolio

            23.3.2.3. Profitability by Market Segments (Vaccine/Channel/Country)

            23.3.2.4. Sales Footprint

            23.3.2.5. Strategy Overview

        23.3.3. Intervac Pvt. Ltd.

            23.3.3.1. Overview

            23.3.3.2. Vaccine Portfolio

            23.3.3.3. Profitability by Market Segments (Vaccine/Channel/Country)

            23.3.3.4. Sales Footprint

            23.3.3.5. Strategy Overview

        23.3.4. Zoetis

            23.3.4.1. Overview

            23.3.4.2. Vaccine Portfolio

            23.3.4.3. Profitability by Market Segments (Vaccine/Channel/Country)

            23.3.4.4. Sales Footprint

            23.3.4.5. Strategy Overview

        23.3.5. Elanco

            23.3.5.1. Overview

            23.3.5.2. Vaccine Portfolio

            23.3.5.3. Profitability by Market Segments (Vaccine/Channel/Country)

            23.3.5.4. Sales Footprint

            23.3.5.5. Strategy Overview

        23.3.6. Merial

            23.3.6.1. Overview

            23.3.6.2. Vaccine Portfolio

            23.3.6.3. Profitability by Market Segments (Vaccine/Channel/Country)

            23.3.6.4. Sales Footprint

            23.3.6.5. Strategy Overview

        23.3.7. Merck & Co. Inc

            23.3.7.1. Overview

            23.3.7.2. Vaccine Portfolio

            23.3.7.3. Profitability by Market Segments (Vaccine/Channel/Country)

            23.3.7.4. Sales Footprint

            23.3.7.5. Strategy Overview

        23.3.8. Bayer Pharma AG

            23.3.8.1. Overview

            23.3.8.2. Vaccine Portfolio

            23.3.8.3. Profitability by Market Segments (Vaccine/Channel/Country)

            23.3.8.4. Sales Footprint

            23.3.8.5. Strategy Overview

        23.3.9. Ceva

            23.3.9.1. Overview

            23.3.9.2. Vaccine Portfolio

            23.3.9.3. Profitability by Market Segments (Vaccine/Channel/Country)

            23.3.9.4. Sales Footprint

            23.3.9.5. Strategy Overview

        23.3.10. Boehringer Ingelheim

            23.3.10.1. Overview

            23.3.10.2. Vaccine Portfolio

            23.3.10.3. Profitability by Market Segments (Vaccine/Channel/Country)

            23.3.10.4. Sales Footprint

            23.3.10.5. Strategy Overview

24. Assumptions and Acronyms Used

25. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Middle East Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Vaccine 

Table 02: Middle East Veterinary Vaccines Market Volume (Units) Analysis 2016-2021 and Forecast 2022-2031, By Vaccine 

Table 03: Middle East Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Animal

Table 04: Middle East Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Disease Indication

Table 05: Middle East Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By End User

Table 06: Middle East Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Country

Table 07: Middle East Veterinary Vaccines Market Volume (Units) Analysis 2016-2021 and Forecast 2022-2031, By Country

Table 08: UAE Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Vaccine

Table 09: UAE Veterinary Vaccines Market Volume (Units) Analysis 2016-2021 and Forecast 2022-2031, By Vaccine

Table 10: UAE Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Animal

Table 11: UAE Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Disease Indication

Table 12: UAE Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By End User

Table 13: KSA Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Vaccine

Table 14: KSA Veterinary Vaccines Market Volume (Units) Analysis 2016-2021 and Forecast 2022-2031, By Vaccine

Table 15: KSA Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Animal

Table 16: KSA Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Disease Indication

Table 17: KSA Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By End User

Table 18: Turkey Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Vaccine

Table 19: Turkey Veterinary Vaccines Market Volume (Units) Analysis 2016-2021 and Forecast 2022-2031, By Vaccine

Table 20: Turkey Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Animal

Table 21: Turkey Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Disease Indication

Table 22: Turkey Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By End User

Table 23: Jordan Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Vaccine

Table 24: Jordan Veterinary Vaccines Market Volume (Units) Analysis 2016-2021 and Forecast 2022-2031, By Vaccine

Table 25: Jordan Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Animal

Table 26: Jordan Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Disease Indication

Table 27: Jordan Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By End User

Table 28: Sudan Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Vaccine

Table 29: Sudan Veterinary Vaccines Market Volume (Units) Analysis 2016-2021 and Forecast 2022-2031, By Vaccine

Table 30: Sudan Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Animal

Table 31: Sudan Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Disease Indication

Table 32: Sudan Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By End User

Table 33: Egypt Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Vaccine

Table 34: Egypt Veterinary Vaccines Market Volume (Units) Analysis 2016-2021 and Forecast 2022-2031, By Vaccine

Table 35: Egypt Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Animal

Table 36: Egypt Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Disease Indication

Table 37: Egypt Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By End User

Table 38: Rest of Middle East Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Vaccine

Table 39: Rest of Middle East Veterinary Vaccines Market Volume (Units) Analysis 2016-2021 and Forecast 2022-2031, By Vaccine

Table 40: Rest of Middle East Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Animal

Table 41: Rest of Middle East Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By Disease Indication

Table 42: Rest of Middle East Veterinary Vaccines Market Size (US$ Mn) Analysis 2016-2021 and Forecast 2022-2031, By End User

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

Figure 01: Middle East Veterinary Vaccines Market Revenue Share by Vaccine, 2022E & 2031F

Figure 02: Middle East Veterinary Vaccines Market Revenue Share by Animal, 2022E & 2031F

Figure 03: Middle East Veterinary Vaccines Market Revenue Share by Disease Indication, 2022E & 2031F

Figure 04: Middle Veterinary Vaccines Market Revenue Share by End User, 2022E & 2031F

Figure 05: Middle East Veterinary Vaccines Market Volume Analysis, 2016-2021

Figure 06: Middle East Veterinary Vaccines Market Volume & Y-o-Y Growth (%) Analysis, 2022-2031

Figure 07: Middle East Average Pricing Analysis (US$) for Veterinary Vaccines Market (2021)

Figure 08: Middle East Veterinary Vaccines Market Size (US$ Mn) Analysis, 2016-2021

Figure 09: Middle East Veterinary Vaccines Market Size (US$ Mn) & Y-o-Y Growth (%) Analysis, 2022-2031

Figure 10: Middle East Veterinary Vaccines Market Absolute $ Opportunity Analysis, 2022-2031

Figure 11: Middle East Veterinary Vaccines Market Analysis by Vaccine, 2022 & 2031

Figure 12: Middle East Veterinary Vaccines Market Y-o-Y Growth Projections by Vaccine, 2022-2031

Figure 13: Middle East Veterinary Vaccines Market Attractiveness, By Vaccine, 2022-2031 

Figure 14: Middle East Veterinary Vaccines Market Analysis by Animal, 2022 & 2031

Figure 15: Middle East Veterinary Vaccines Market Y-o-Y Growth Projections by Animal, 2022-2031

Figure 16: Middle East Veterinary Vaccines Market Attractiveness, By Animal, 2022-2031 

Figure 17: Middle East Veterinary Vaccines Market Analysis by Disease Indication, 2022 & 2031

Figure 18: Middle East Veterinary Vaccines Market Y-o-Y Growth Projections by Disease Indication, 2022-2031

Figure 19: Middle East Veterinary Vaccines Market Attractiveness, By Disease Indication, 2022-2031 

Figure 20: Middle East Veterinary Vaccines Market Analysis by End User, 2022 & 2031

Figure 21: Middle East Veterinary Vaccines Market Y-o-Y Growth Projections by End User, 2022-2031

Figure 22: Middle East Veterinary Vaccines Market Attractiveness, By End User, 2022-2031 

Figure 23: Middle East Veterinary Vaccines Market Analysis by Country, 2022 & 2031

Figure 24: Middle East Veterinary Vaccines Market Y-o-Y Growth Projections by Country, 2022-2031

Figure 25: Middle East Veterinary Vaccines Market Attractiveness, By Country, 2022-2031 

Figure 26: UAE Veterinary Vaccines Market Size (US$ Mn) Analysis, 2016-2021

Figure 27: UAE Veterinary Vaccines Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2031

Figure 28: UAE Veterinary Vaccines Market Share, By Vaccine (2022)

Figure 29: UAE Veterinary Vaccines Market Share, By Animal (2022)

Figure 30: UAE Veterinary Vaccines Market Share, By Disease Indication (2022)

Figure 31: UAE Veterinary Vaccines Market Share, By End User (2022)

Figure 32: UAE Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by Vaccine

Figure 33: UAE Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by Animal

Figure 34: UAE Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by Disease Indication

Figure 35: UAE Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by End User

Figure 36: KSA Veterinary Vaccines Market Size (US$ Mn) Analysis, 2016-2021

Figure 37: KSA Veterinary Vaccines Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2031

Figure 38: KSA Veterinary Vaccines Market Share, By Vaccine (2022)

Figure 39: KSA Veterinary Vaccines Market Share, By Animal (2022)

Figure 40: KSA Veterinary Vaccines Market Share, By Disease Indication (2022)

Figure 41: KSA Veterinary Vaccines Market Share, By End User (2022)

Figure 42: KSA Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by Vaccine

Figure 43: KSA Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by Animal

Figure 44: KSA Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by Disease Indication

Figure 45: KSA Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by End User

Figure 46: Turkey Veterinary Vaccines Market Size (US$ Mn) Analysis, 2016-2021

Figure 47: Turkey Veterinary Vaccines Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2031

Figure 48: Turkey Veterinary Vaccines Market Share, By Vaccine (2022)

Figure 49: Turkey Veterinary Vaccines Market Share, By Animal (2022)

Figure 50: Turkey Veterinary Vaccines Market Share, By Disease Indication (2022)

Figure 51: Turkey Veterinary Vaccines Market Share, By End User (2022)

Figure 52: Turkey Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by Vaccine

Figure 53: Turkey Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by Animal

Figure 54: Turkey Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by Disease Indication

Figure 55: Turkey Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by End User

Figure 56: Jordan Veterinary Vaccines Market Size (US$ Mn) Analysis, 2016-2021

Figure 57: Jordan Veterinary Vaccines Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2031

Figure 58: Jordan Veterinary Vaccines Market Share, By Vaccine (2022)

Figure 59: Jordan Veterinary Vaccines Market Share, By Animal (2022)

Figure 60: Jordan Veterinary Vaccines Market Share, By Disease Indication (2022)

Figure 61: Jordan Veterinary Vaccines Market Share, By End User (2022)

Figure 62: Jordan Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by Vaccine

Figure 63: Jordan Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by Animal

Figure 64: Jordan Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by Disease Indication

Figure 65: Jordan Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by End User

Figure 66: Sudan Veterinary Vaccines Market Size (US$ Mn) Analysis, 2016-2021

Figure 67: Sudan Veterinary Vaccines Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2031

Figure 68: Sudan Veterinary Vaccines Market Share, By Vaccine (2022)

Figure 69: Sudan Veterinary Vaccines Market Share, By Animal (2022)

Figure 70: Sudan Veterinary Vaccines Market Share, By Disease Indication (2022)

Figure 71: Sudan Veterinary Vaccines Market Share, By End User (2022)

Figure 72: Sudan Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by Vaccine

Figure 73: Sudan Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by Animal

Figure 74: Sudan Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by Disease Indication

Figure 75: Sudan Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by End User

Figure 76: Egypt Veterinary Vaccines Market Size (US$ Mn) Analysis, 2016-2021

Figure 77: Egypt Veterinary Vaccines Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2031

Figure 78: Egypt Veterinary Vaccines Market Share, By Vaccine (2022)

Figure 79: Egypt Veterinary Vaccines Market Share, By Animal (2022)

Figure 80: Egypt Veterinary Vaccines Market Share, By Disease Indication (2022)

Figure 81: Egypt Veterinary Vaccines Market Share, By End User (2022)

Figure 82: Egypt Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by Vaccine

Figure 83: Egypt Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by Animal

Figure 84: Egypt Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by Disease Indication

Figure 85: Egypt Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by End User

Figure 86: Rest of Middle East Veterinary Vaccines Market Size (US$ Mn) Analysis, 2016-2021

Figure 87: Rest of Middle East Veterinary Vaccines Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2031

Figure 88: Rest of Middle East Veterinary Vaccines Market Share, By Vaccine (2022)

Figure 89: Rest of Middle East Veterinary Vaccines Market Share, By Animal (2022)

Figure 90: Rest of Middle East Veterinary Vaccines Market Share, By Disease Indication (2022)

Figure 91: Rest of Middle East Veterinary Vaccines Market Share, By End User (2022)

Figure 92: Rest of Middle East Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by Vaccine

Figure 93: Rest of Middle East Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by Animal

Figure 94: Rest of Middle East Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by Disease Indication

Figure 95: Rest of Middle East Veterinary Vaccines Market Attractiveness Analysis 2022-2031 by End User

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Downstream Processing Market

Published : September 2017

Healthcare

Veterinary Ultrasound Scanners Market

Published : January 2022

Healthcare

Middle East Veterinary Vaccines Market

Published : February 2022

Healthcare

Pediatric Vaccine Market

Published : December 2016

Google translate

Middle East Veterinary Vaccines Market